share_log

Sonoma Pharmaceuticals Q2 EPS $(0.29) Misses $(0.24) Estimate, Sales $2.73M Miss $3.48M Estimate

Benzinga ·  Nov 13, 2023 17:39

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by 20.83 percent. This is a 12.12 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $2.73 million which missed the analyst consensus estimate of $3.48 million by 21.52 percent. This is a 18.01 percent decrease over sales of $3.33 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment